1
|
Ha SM, Chae EY, Cha JH, Kim HH, Shin HJ, Choi WJ. Breast MR Imaging before Surgery: Outcomes in Patients with Invasive Lobular Carcinoma by Using Propensity Score Matching. Radiology 2018; 287:771-777. [DOI: 10.1148/radiol.2018171472] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Su Min Ha
- From the Department of Radiology, Research Institute of Radiology, Chung-Ang University Hospital, Seoul, Korea (S.M.H.); and Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43 gil, Songpa-gu, Seoul 05505, Korea (E.Y.C., J.H.C., H.H.K., H.J.S., W.J.C.)
| | - Eun Young Chae
- From the Department of Radiology, Research Institute of Radiology, Chung-Ang University Hospital, Seoul, Korea (S.M.H.); and Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43 gil, Songpa-gu, Seoul 05505, Korea (E.Y.C., J.H.C., H.H.K., H.J.S., W.J.C.)
| | - Joo Hee Cha
- From the Department of Radiology, Research Institute of Radiology, Chung-Ang University Hospital, Seoul, Korea (S.M.H.); and Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43 gil, Songpa-gu, Seoul 05505, Korea (E.Y.C., J.H.C., H.H.K., H.J.S., W.J.C.)
| | - Hak Hee Kim
- From the Department of Radiology, Research Institute of Radiology, Chung-Ang University Hospital, Seoul, Korea (S.M.H.); and Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43 gil, Songpa-gu, Seoul 05505, Korea (E.Y.C., J.H.C., H.H.K., H.J.S., W.J.C.)
| | - Hee Jung Shin
- From the Department of Radiology, Research Institute of Radiology, Chung-Ang University Hospital, Seoul, Korea (S.M.H.); and Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43 gil, Songpa-gu, Seoul 05505, Korea (E.Y.C., J.H.C., H.H.K., H.J.S., W.J.C.)
| | - Woo Jung Choi
- From the Department of Radiology, Research Institute of Radiology, Chung-Ang University Hospital, Seoul, Korea (S.M.H.); and Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43 gil, Songpa-gu, Seoul 05505, Korea (E.Y.C., J.H.C., H.H.K., H.J.S., W.J.C.)
| |
Collapse
|
2
|
Derias M, Subramanian A, Allan S, Shah E, Teraifi HE, Howlett D. The Role of Magnetic Resonance Imaging in the Investigation and Management of Invasive Lobular Carcinoma-A 3-Year Retrospective Study in Two District General Hospitals. Breast J 2016; 22:384-9. [DOI: 10.1111/tbj.12594] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Mina Derias
- Breast Surgery Department - East Sussex Healthcare NHS Trust; Eastbourne District General Hospital; Eastbourne UK
| | - Ashok Subramanian
- Breast Surgery Department - East Sussex Healthcare NHS Trust; Eastbourne District General Hospital; Eastbourne UK
| | - Simon Allan
- Breast Surgery Department - East Sussex Healthcare NHS Trust; Eastbourne District General Hospital; Eastbourne UK
| | - Elizabeth Shah
- Breast Surgery Department - East Sussex Healthcare NHS Trust; Eastbourne District General Hospital; Eastbourne UK
| | - Hassan El Teraifi
- Histopathology Department - East Sussex Healthcare NHS Trust; Eastbourne District General Hospital; Eastbourne UK
| | - David Howlett
- Radiology Department - East Sussex Healthcare NHS Trust; Eastbourne District General Hospital; Eastbourne UK
| |
Collapse
|
3
|
Parvaiz MA, Yang P, Razia E, Mascarenhas M, Deacon C, Matey P, Isgar B, Sircar T. Breast
MRI
in Invasive Lobular Carcinoma: A Useful Investigation in Surgical Planning? Breast J 2016; 22:143-50. [PMID: 26841281 DOI: 10.1111/tbj.12566] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- Muhammad Asad Parvaiz
- Department of Breast & Oncoplastic Surgery Peterborough and Stamford Hospitals NHS Foundation Trust Peterborough Cambridgeshire UK
| | - Peiming Yang
- Department of Breast & Oncoplastic Surgery The Royal Wolverhampton Hospitals NHS Trust West Midlands UK
| | - Eisha Razia
- Department of Breast & Oncoplastic Surgery The Royal Wolverhampton Hospitals NHS Trust West Midlands UK
| | - Margaret Mascarenhas
- Department of Breast & Oncoplastic Surgery The Royal Wolverhampton Hospitals NHS Trust West Midlands UK
| | - Caroline Deacon
- Department of Radiology The Royal Wolverhampton Hospitals NHS Trust West Midlands UK
| | - Pilar Matey
- Department of Breast & Oncoplastic Surgery The Royal Wolverhampton Hospitals NHS Trust West Midlands UK
| | - Brian Isgar
- Department of Breast & Oncoplastic Surgery The Royal Wolverhampton Hospitals NHS Trust West Midlands UK
| | - Tapan Sircar
- Department of Breast & Oncoplastic Surgery The Royal Wolverhampton Hospitals NHS Trust West Midlands UK
| |
Collapse
|
4
|
Jung NY, Kim SH, Kim SH, Seo YY, Oh JK, Choi HS, You WJ. Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma. J Breast Cancer 2015; 18:63-72. [PMID: 25834613 PMCID: PMC4381125 DOI: 10.4048/jbc.2015.18.1.63] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2014] [Accepted: 11/27/2014] [Indexed: 11/30/2022] Open
Abstract
Purpose We evaluated the utility of magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for the preoperative staging of invasive lobular carcinoma (ILC) of the breast and compared the results with those of invasive ductal carcinoma (IDC). Methods The study included pathologically proven 32 ILCs and 73 IDCs. We compared clinical and histopathological characteristics and the diagnostic performances of MRI and 18F-FDG PET/CT for the primary mass, additional ipsilateral and/or contralateral lesion(s), and axillary lymph node metastasis between the ILC and IDC groups. Results Primary ILCs were greater in size, but demonstrated lower maximum standardized uptake values than IDCs. All primary masses were detected on MRI. The detection rate for ILCs (75.0%) was lower than that for IDCs (83.6%) on 18F-FDG PET/CT, but the difference was not significant. For additional ipsilateral lesion(s), the sensitivities and specificities of MRI were 87.5% and 58.3% for ILC and 100.0% and 66.7% for IDC, respectively; whereas the sensitivities and specificities of 18F-FDG PET/CT were 0% and 91.7% for ILC and 37.5% and 94.7% for IDC, respectively. The sensitivity of 18F-FDG PET/CT for ipsilateral lesion(s) was significantly lower in the ILC group than the IDC group. The sensitivity for ipsilateral lesion(s) was significantly higher with MRI; however, specificity was higher with 18F-FDG PET/CT in both tumor groups. There was no significant difference in the diagnostic performance for additional contralateral lesion(s) or axillary lymph node metastasis on MRI or 18F-FDG PET/CT for ILC versus IDC. Conclusion The MRI and 18F-FDG PET/CT detection rates for the primary cancer do not differ between the ILC and IDC groups. Although 18F-FDG PET/CT demonstrates lower sensitivity for primary and additional ipsilateral lesions, it shows higher specificity for additional ipsilateral lesions, and could play a complementary role in the staging of ILC as well as IDC.
Collapse
Affiliation(s)
- Na Young Jung
- Department of Radiology, Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Bucheon, Korea
| | - Sung Hoon Kim
- Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
| | - Sung Hun Kim
- Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
| | - Ye Young Seo
- Department of Radiology, Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
| | - Jin Kyoung Oh
- Department of Radiology, Incheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Incheon, Korea
| | - Hyun Su Choi
- Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea
| | - Won Jong You
- Department of Radiology, Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Bucheon, Korea
| |
Collapse
|
5
|
Sikora MJ, Jankowitz RC, Dabbs DJ, Oesterreich S. Invasive lobular carcinoma of the breast: patient response to systemic endocrine therapy and hormone response in model systems. Steroids 2013. [PMID: 23178159 DOI: 10.1016/j.steroids.2012.11.002] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Invasive lobular carcinoma of the breast (ILC) represents 10-15% of all newly diagnosed breast cancers, affecting ∼30,000 women annually in the United States. However, ILC is critically understudied as a breast cancer subtype. Though the vast majority of ILC are estrogen receptor-positive and present with overall favorable biomarkers, ILC patients do not benefit from improved outcomes versus other breast cancer patients. Patient outcomes, in particular in response to endocrine therapies, are not well understood in ILC, due in large part to the lack of prospective identification in large clinical trials. Further, there is a lack of laboratory models to study cell signaling, hormone response, and endocrine resistance in ILC. In this review, we provide an overview of clinicopathological features of ILC tumors, discuss issues with clinical management, and highlight the disconnect between ILC biomarkers and patient outcomes. We review currently available data on ILC patient outcomes, with a focus on response to endocrine therapy. Additionally, we describe currently available laboratory models for understanding hormone response in ILC cells, and review current data on these model systems. The promise for new insight into ILC, based on extensive representation of the disease in recent large scale genomic studies, is also discussed. Increasing understanding of endocrine response in ILC represents a critical area for future research to improve patient outcomes for this understudied breast cancer subtype.
Collapse
Affiliation(s)
- Matthew J Sikora
- Department of Pharmacology and Chemical Biology, University of Pittsburgh, United States
| | | | | | | |
Collapse
|